BNTC short interest

Benitec Biopharma · settlement of Oct 30, 2026

As of Oct 30, 2026, 2.0M BNTC shares were sold short, up 0.1% from the Oct 15, 2026 count. At the stock's average daily volume, that is 11 days to cover.

Benitec Biopharma research · BNTC trades by Congress · Short interest movers · Most shorted stocks · Source

Shares sold short
2.0M1,994,400
Change
+0.1%from 2.0M
Of shares outstanding
5.72%#1,546 of 3,781 stocks measured
Days to cover
11at the average daily volume
Average daily volume
176,530shares, as FINRA reports it
Most in 16 settlements
2.4MJun 15, 2026

Every settlement

16 settlements, newest first
SettlementShares shortChangeAvg daily volumeDays to cover
Oct 30, 20261,994,400+0.1%176,53011
Oct 15, 20261,992,032−2.3%197,76110
Sep 30, 20262,039,457−6.7%200,14710
Sep 15, 20262,186,142−1.3%109,46320
Aug 31, 20262,214,538+5.1%154,96214
Aug 14, 20262,107,348−1.8%211,9869.9
Jul 31, 20262,146,708−5.4%80,28327
Jul 15, 20262,269,662+1.8%96,65723
Jun 30, 20262,228,682−7.3%214,32210
Jun 15, 20262,405,071+3.1%83,37029
May 29, 20262,332,180+3.6%75,77931
May 15, 20262,251,632−2.9%97,93523
Apr 30, 20262,318,612+2.3%107,71722
Apr 15, 20262,266,291−1.7%104,87622
Mar 31, 20262,305,987+7.1%168,95214
Mar 13, 20262,152,891—257,7748.3

Source

Short interest is the number of shares sold short and not yet bought back. Brokers report it to FINRA for two settlement dates a month, the middle and the end, and FINRA publishes each count about a week later. It is not a daily figure: between settlements no one publishes a count. Days to cover is the short interest divided by the average daily volume FINRA reports beside it. A rising count is shown in red and a falling one in green.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.